KOMBIGLYZE
These highlights do not include all the information needed to use KOMBIGLYZE XR safely and effectively. See full prescribing information for KOMBIGLYZE XR. KOMBIGLYZE XR (saxagliptin and metformin hydrochloride extended-release) tablets, for oral useInitial U.S. Approval: 2010
fbd25da4-ebe6-45c9-beb8-93523d11a0b4
HUMAN PRESCRIPTION DRUG LABEL
Oct 24, 2019
AstraZeneca Pharmaceuticals LP
DUNS: 054743190
Products 3
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (7)
SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (5)
SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE
Product Details
FDA regulatory identification and product classification information